Perspectives and potential approaches for targeting neuropilin 1 in SARS-CoV-2 infection.

Perspectives and potential approaches for targeting neuropilin 1 in SARS-CoV-2 infection.
复制标题

在SARS-CoV-2感染中靶向神经纤毛蛋白1的前景和潜在方法

DOI:
10.1186/s10020-021-00423-y
复制
发表时间:
2021-12-27
期刊:
Molecular medicine (Cambridge, Mass.)
影响因子:
--
通讯作者:
Keegan AD
Keegan AD
中科院分区:
其他
文献类型:
--
作者:
Chapoval SP;Keegan AD

文献摘要

参考文献

被引文献

相似文献

严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)是导致COVID-19大流行的新型b型冠状病毒。由于该病毒确诊感染超过2.24亿人,死亡人数超过460万人,因此,确定人类对该病毒反应中发生的免疫过程及其致命表现的发病机制至关重要。这一观点的重点是最近发现的SARS-CoV-2刺突蛋白与神经匹林1 (NRP1)受体的相互作用,NRP1作为SARS-CoV-2的病毒进入受体,其在不同生理和病理条件下的作用,以及靶向刺突- NRP1相互作用以对抗病毒传染性和严重疾病表现的潜力。
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel type b coronavirus responsible for the COVID-19 pandemic. With over 224 million confirmed infections with this virus and more than 4.6 million people dead because of it, it is critically important to define the immunological processes occurring in the human response to this virus and pathogenetic mechanisms of its deadly manifestation. This perspective focuses on the contribution of the recently discovered interaction of SARS-CoV-2 Spike protein with neuropilin 1 (NRP1) receptor, NRP1 as a virus entry receptor for SARS-CoV-2, its role in different physiologic and pathologic conditions, and the potential to target the Spike–NRP1 interaction to combat virus infectivity and severe disease manifestations.
DOI: 10.3390/cells9092046
发表时间: 2020-09-08
期刊: Cells
影响因子: 6
作者:
Campana P;Parisi V;Leosco D;Bencivenga D;Della Ragione F;Borriello A
通讯作者: Borriello A
DOI: 10.1126/science.abd3072
发表时间: 2020-11-13
期刊: Science (New York, N.Y.)
影响因子: --
作者:
Daly JL;Simonetti B;Klein K;Chen KE;Williamson MK;Antón-Plágaro C;Shoemark DK;Simón-Gracia L;Bauer M;Hollandi R;Greber UF;Horvath P;Sessions RB;Helenius A;Hiscox JA;Teesalu T;Matthews DA;Davidson AD;Collins BM;Cullen PJ;Yamauchi Y
通讯作者: Yamauchi Y
危及生命的Covid-19患者中针对I型IFN的自身抗体。
DOI: 10.1126/science.abd4585
发表时间: 2020-10-23
期刊: Science (New York, N.Y.)
影响因子: --
作者:
Bastard P;Rosen LB;Zhang Q;Michailidis E;Hoffmann HH;Zhang Y;Dorgham K;Philippot Q;Rosain J;Béziat V;Manry J;Shaw E;Haljasmägi L;Peterson P;Lorenzo L;Bizien L;Trouillet-Assant S;Dobbs K;de Jesus AA;Belot A;Kallaste A;Catherinot E;Tandjaoui-Lambiotte Y;Le Pen J;Kerner G;Bigio B;Seeleuthner Y;Yang R;Bolze A;Spaan AN;Delmonte OM;Abers MS;Aiuti A;Casari G;Lampasona V;Piemonti L;Ciceri F;Bilguvar K;Lifton RP;Vasse M;Smadja DM;Migaud M;Hadjadj J;Terrier B;Duffy D;Quintana-Murci L;van de Beek D;Roussel L;Vinh DC;Tangye SG;Haerynck F;Dalmau D;Martinez-Picado J;Brodin P;Nussenzweig MC;Boisson-Dupuis S;Rodríguez-Gallego C;Vogt G;Mogensen TH;Oler AJ;Gu J;Burbelo PD;Cohen JI;Biondi A;Bettini LR;D'Angio M;Bonfanti P;Rossignol P;Mayaux J;Rieux-Laucat F;Husebye ES;Fusco F;Ursini MV;Imberti L;Sottini A;Paghera S;Quiros-Roldan E;Rossi C;Castagnoli R;Montagna D;Licari A;Marseglia GL;Duval X;Ghosn J;HGID Lab;NIAID-USUHS Immune Response to COVID Group;COVID Clinicians;COVID-STORM Clinicians;Imagine COVID Group;French COVID Cohort Study Group;Milieu Intérieur Consortium;CoV-Contact Cohort;Amsterdam UMC Covid-19 Biobank;COVID Human Genetic Effort;Tsang JS;Goldbach-Mansky R;Kisand K;Lionakis MS;Puel A;Zhang SY;Holland SM;Gorochov G;Jouanguy E;Rice CM;Cobat A;Notarangelo LD;Abel L;Su HC;Casanova JL
通讯作者: Casanova JL
DOI: 10.1007/s40475-020-00201-6
发表时间: 2020-06-01
影响因子: 5.4
作者:
Chen, Wen-Hsiang;Strych, Ulrich;Bottazzi, Maria Elena
通讯作者: Bottazzi, Maria Elena
DOI: 10.4049/immunohorizons.1800026
发表时间: 2019-02-01
期刊: ImmunoHorizons
影响因子: --
作者:
Chapoval, Svetlana P;Hritzo, Molly;Keegan, Achsah D
通讯作者: Keegan, Achsah D